OxSonics Ltd.
Ultrasound-activated nanoparticles deliver drugs, repair spines
This article was originally published in Start Up
Executive Summary
One shortcoming of many cancer drugs is their limited ability to reach deep into solid tumors. OxSonics Ltd. hopes to improve on this with SonoTran, an ultrasound device that activates sono-sensitive nanoparticles to push drug molecules deeper into tumors.